Lucas Franki is an associate editor for MDedge News, and has been with the company since 2014. He has a BA in English from Penn State University and is an Eagle Scout.
News
Pathogenic ball pits, zombie bacteria, and OTC beer
And heart failure patients could soon take a seat in the, ahem, oval office.
News
FDA approves solriamfetol for daytime sleepiness treatment
Solriamfetol is the first dopamine and norepinephrine reuptake inhibitor approved to treat narcolepsy and obstructive sleep apnea.
News
Patients with OCD/hoarding differ from those with OCD/nonhoarding
“Clinical implications of our findings are to have the treatment follow a more intensive and structured course (i.e. avoid surprises).”
News
Biogen, Eisai discontinue aducanumab Alzheimer’s trials
All trials – the phase 3 ENGAGE and EMERGE trials, phase 2 EVOLVE safety study, and the long-term extension of the phase 1b PRIME study – have...
News
Sleepless democracy, space herpes, and the F-bomb diet
And why you really, really do not want to lick surfaces on the International Space Station.
News
Disease burden in OA worse than RA 6 months post presentation
RAPID3 scores improved after 6 months for both RA and OA patients, but RA patients saw greater reductions.
News
FDA approves atezolizumab for first-line ES-SCLC treatment
Approval was based on improved overall survival demonstrated in the phase 3 IMpower133 study of 403 treatment-naive patients with extensive-stage...
News
Match Day 2019: Dermatology steps up growth after slow 2018
Nearly all PGY-2 dermatology slots were filled in the 2019 Match.
News
Match Day 2019: Psychiatry sees double-digit growth
Match Day 2019 was another record breaker, and psychiatry helped play a big role by offering nearly 200 more residency slots and matches than in...
News
Friendly gut bugs, MCI-battling mushrooms, and remembering to forget
And how one button-holing golfing great kept his health care funding on the fairway.
News
ACC to offer new certification for transcatheter valve repair, replacement
The Transcatheter Valve Certification will be launched in mid-2019.
News
FDA approves new valsartan generic
FDA commissioner: “We’ve prioritized the review of generic applications for these valsartan products” to address angiotensin II receptor blocker...
News
FDA approves another trastuzumab biosimilar for HER2-positive breast cancer, gastric cancer
The Food and Drug Administration has approved Trazimera (trastuzumab-qyyp), a biosimilar of ...
News
FDA approves patient-controlled injector for guselkumab
The Food and Drug Administration has